文献速递脑血管病

心源性栓塞性卒中风险与抗凝相关脑出血后的恢复

Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage.
PubMed 文献 · Stroke · 2018-01-01

该研究联合分析3项观察性研究共941例因非瓣膜性心房颤动服用口服抗凝药预防心源性栓塞而发生脑出血的幸存者,且1年时无缺血性卒中及复发性脑出血证据。多变量分析显示,CHA2DS2-VASc评分每增加1分,1年功能恢复的可能性降低(比值比0.83,95%CI 0.79-0.86);恢复抗凝与更高的恢复可能性独立相关(比值比1.89,95%CI 1.32-2.70),且CHA2DS2-VASc评分与恢复抗凝之间存在交互作用(交互P=0.011)。

要点

  • CHA2DS2-VASc评分每增加1分,1年功能恢复可能性降低(比值比0.83,95%CI 0.79-0.86)。
  • 恢复口服抗凝与1年功能恢复可能性升高独立相关(比值比1.89,95%CI 1.32-2.70)。
  • CHA2DS2-VASc评分与恢复抗凝对功能恢复存在交互作用(交互P=0.011)。

核心结论

  • 心源性栓塞性卒中风险增加与脑出血后1年功能恢复可能性降低相关,但在恢复口服抗凝治疗的参与者中该关联较弱。
  • 这些发现支持在未来关于脑出血后恢复抗凝治疗的研究中纳入恢复指标。

研究设计与样本

  • 联合分析3项观察性研究:多中心RETRACE研究(德国全国多中心口服抗凝相关脑出血分析)、马萨诸塞州总医院脑出血研究(n=166)和ERICH研究(脑出血的种族/民族差异;n=131)。
  • 纳入941例因非瓣膜性心房颤动接受口服抗凝治疗预防心源性栓塞而发生脑出血的幸存者,且从索引事件起1年内无缺血性卒中及复发性脑出血证据。
  • 采用单变量和多变量模型探索基于CHA2DS2-VASc评分的心源性栓塞性卒中风险与脑出血后功能恢复之间的关联,功能恢复定义为出院时改良Rankin量表评分>3分的参与者在1年时达到改良Rankin量表评分≤3分。

主要发现

  • 多变量分析中,CHA2DS2-VASc评分与1年功能恢复可能性降低相关(比值比0.83,每增加1分;95%CI 0.79-0.86)。
  • 恢复抗凝与更高的恢复可能性独立相关,无论CHA2DS2-VASc评分如何(比值比1.89;95%CI 1.32-2.70)。
  • CHA2DS2-VASc评分与恢复抗凝在与功能恢复可能性增加的关联上存在交互作用(交互P=0.011)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background and Purpose- Whether to resume oral anticoagulation treatment after intracerebral hemorrhage (ICH) remains an unresolved question. Previous studies focused primarily on recurrent stroke after ICH. We sought to investigate the association between cardioembolic stroke risk, oral anticoagulation therapy resumption, and functional recovery among ICH survivors in the absence of recurrent stroke. Methods- We conducted a joint analysis of 3 observational studies: (1) the multicenter RETRACE study (German-Wide Multicenter Analysis of Oral Anticoagulation Associated Intracerebral Hemorrhage); (2) the Massachusetts General Hospital ICH study (n=166); and (3) the ERICH study (Ethnic/Racial Variations of Intracerebral Hemorrhage; n=131). We included 941 survivors of ICH in the setting of active oral anticoagulation therapy for prevention of cardioembolic stroke because of nonvalvular atrial fibrillation and without evidence of ischemic stroke and recurrent ICH at 1 year from the index event. We created univariable and multivariable models to explore associations between cardioembolic stroke risk (based on CHA2DS2-VASc scores) and functional recovery after ICH, defined as achieving modified Rankin Scale score of ≤3 at 1 year for participants with modified Rankin Scale score of >3 at discharge. Results- In multivariable analyses, the CHA2DS2-VASc score was associated with a decreased likelihood of functional recovery (odds ratio, 0.83 per 1 point increase; 95% CI, 0.79-0.86) at 1 year. Anticoagulation resumption was independently associated with a higher likelihood of recovery, regardless of CHA2DS2-VASc score (odds ratio, 1.89; 95% CI, 1.32-2.70). We found an interaction between CHA2DS2-VASc score and anticoagulation resumption in terms of association with increased likelihood of functional recovery (interaction P=0.011). Conclusions- Increasing cardioembolic stroke risk is associated with a decreased likelihood of functional recovery at 1 year after ICH, but this association was weaker among participants resuming oral anticoagulation therapy. These findings support, including recovery metrics, in future studies of anticoagulation resumption after ICH.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Murphy MP, Kuramatsu JB, Leasure A, et al. Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage. Stroke. 2018. PMID: 30355194. doi:10.1161/STROKEAHA.118.021799

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。